DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...
DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...
Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER, Sept. 13, 2023 /PRNewswire/ -- DaVita Inc....
Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER, Sept. 12, 2023 /PRNewswire/ -- DaVita Inc., a leading kidney care provider,...
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted...